ArticleBiomedicines2022

Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells.

Sergei Boichuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.